Inventor
HASUI TOMOAKI
JP17 patents
⚠️ This page may combine multiple inventors who share the name “HASUI TOMOAKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
6 patentsUS11939327B2Mar 26, 2024
Heterocyclic compounds
TAKEDA PHARMACEUTICALS CO0 citations62
US11447488B2Sep 20, 2022
Heterocyclic compounds
TAKEDA PHARMACEUTICALS CO1 citations62
US11407748B2Aug 9, 2022
Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
TAKEDA PHARMACEUTICALS CO1 citations62
US10112956B2Oct 30, 2018
Heterocyclic compounds having cholesterol 24-hydroxylase activity
TAKEDA PHARMACEUTICALS CO1 citations51
US9624184B2Apr 18, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations51
US12590086B2Mar 31, 2026
3-((1H-pyrazol-4-yl)methyl)-6′-(phenyl)-2H-(1,2′-bipyridin)-2-one derivatives and related compounds as GPR139 antagonists for use in a method of treatment of e.g. depression
TAKEDA PHARMACEUTICALS CO0 citations50
TANIGUCHI TAKAHIKO
5 patentsUS9150588B2Oct 6, 2015
Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
TANIGUCHI TAKAHIKO5 citations72
US8846713B2Sep 30, 2014
Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors
TANIGUCHI TAKAHIKO2 citations61
US8563575B2Oct 22, 2013
Fused heterocyclic compounds
TANIGUCHI TAKAHIKO4 citations60
US9029388B2May 12, 2015
Condensed heterocyclic compound
TANIGUCHI TAKAHIKO1 citations50
US9579407B2Feb 28, 2017
Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals
TANIGUCHI TAKAHIKO1 citations45